This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pandey, A. V. Articles by Flück, C. E. Search for Related Content PubMed PubMed Citation Articles by Pandey, A. V. Articles by Flück, C. E.

Modulation of Human CYP19A1 Activity by Mutant NADPH P450 Oxidoreductase

Pediatric Endocrinology, Diabetology & Metabolism, and Department of Clinical Research, University of Bern, CH-3010 Bern, Switzerland

Address all correspondence and requests for reprints to: Christa E. Flück, M.D., Pediatric Endocrinology and Diabetology, University of Bern, Freiburgstrasse 15, G3 812, CH-3010 Bern, Switzerland. E-mail: christa.flueck{at}insel.ch.

Mutations in NADPH P450 oxidoreductase (POR) cause a broad spectrum of human disease with abnormalities in steroidogenesis. We have studied the impact of P450 reductase mutations on the activity of CYP19A1. POR supported CYP19A1 activity with a calculated K_m of 126 nM for androstenedione and a V_max of 1.7 pmol/min. Mutations R457H and V492E located in the FAD domain of POR that disrupt electron transfer caused a complete loss of CYP19A1 activity. The A287P mutation of POR decreased the activities of CYP17A1 by 60–80% but had normal CYP19A1 activity. Molecular modeling and protein docking studies suggested that A287P is involved in the interaction of POR:CYP17A1 but not in the POR:CYP19A1 interaction. Mutations C569Y and V608F in the NADPH binding domain of POR had 49 and 28% of activity of CYP19A1 compared with normal reductase and were more sensitive to the amount of NADPH available for supporting CYP19A1 activity. Substitution of NADH for NADPH had a higher impact on C569Y and V608F mutants of POR. Similar effects were obtained at low/high (5.5/8.5) pH, but using octanol to limit the flux of electrons from POR to CYP19A1 inhibited activity supported by all variants. High molar ratios of KCl also reduced the CYP19A1 supporting activities of C569Y and V608F mutants of POR to a greater extent compared to normal POR and A287P mutant. Because POR supports many P450s involved in steroidogenesis, bone formation, and drug metabolism, variations in the effects of POR mutations on specific enzyme activities may explain the broad clinical spectrum of POR deficiency.

This article has been cited by other articles:

				T. Sahakitrungruang, N. Huang, M. K. Tee, V. Agrawal, W. E. Russell, P. Crock, N. Murphy, C. J. Migeon, and W. L. Miller Clinical, Genetic, and Enzymatic Characterization of P450 Oxidoreductase Deficiency in Four Patients J. Clin. Endocrinol. Metab., December 1, 2009; 94(12): 4992 - 5000. [Abstract] [Full Text] [PDF]

				M. Fukami, G. Nishimura, K. Homma, T. Nagai, K. Hanaki, A. Uematsu, T. Ishii, C. Numakura, H. Sawada, M. Nakacho, et al. Cytochrome P450 Oxidoreductase Deficiency: Identification and Characterization of Biallelic Mutations and Genotype-Phenotype Correlations in 35 Japanese Patients J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1723 - 1731. [Abstract] [Full Text] [PDF]

				L. G. Gomes, N. Huang, V. Agrawal, B. B. Mendonca, T. A. S. S. Bachega, and W. L. Miller Extraadrenal 21-Hydroxylation by CYP2C19 and CYP3A4: Effect on 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 89 - 95. [Abstract] [Full Text] [PDF]

				L. G. Gomes, N. Huang, V. Agrawal, B. B. Mendonca, T. A. S. S. Bachega, and W. L. Miller The Common P450 Oxidoreductase Variant A503V Is Not a Modifier Gene for 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2913 - 2916. [Abstract] [Full Text] [PDF]

				N. Huang, V. Agrawal, K. M. Giacomini, and W. L. Miller Genetics of P450 oxidoreductase: Sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations PNAS, February 5, 2008; 105(5): 1733 - 1738. [Abstract] [Full Text] [PDF]